Profile
CVM VRTX REGN VRNA ARGX ALNY
Company Name CEL-SCI Corporation Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $36.01M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.04K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Geert R. Kersten Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
CVM VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
CVM VRTX REGN VRNA ARGX ALNY
Last Close $6.5 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $12.92 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.19 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -49.69 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 3321.05 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
CVM VRTX REGN VRNA ARGX ALNY
1 Month Return -26.55 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -26.55 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 2814.8 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 1358.05 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 1525.41 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 907.44 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CVM VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -449.25 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
CVM VRTX REGN VRNA ARGX ALNY
Asset Growth 104212.36 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 2.12 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year -100 % 73.64 % - 775.72 %
Revenue 10 Year -100 % 285.02 % - 2487.4 %
EBIT Growth 5.4 % 9.09 % -131.37 % 24.59 %
Net Income Growth 5.61 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 76.45 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 76.18 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 97.67 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 5.85 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -90908.18 % - -143.33 % -107.98 %
Operating 3 Year CFG -33183.1 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -33757.32 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -2185.46 % -100 % 40.15 % 97.08 %
EPS Growth 53.56 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 53.56 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 60708.2 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -82.41 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -75.56 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 109.71 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 80643.51 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -90653.05 % - -144.48 % -201.54 %
Updated On 30 Sep 2025 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
CVM VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -0.09 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -240.36 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -0.11 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 102.42 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -0.18 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 3.66 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 12.81 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -2.14 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.14 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 136650.06 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.22 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -0.18 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -2.1 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -2.45 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -2.45 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
CVM VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.02B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.03B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -6.27 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
CVM VRTX REGN VRNA ARGX ALNY
Long Term Debt $6.95B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $12.2B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $15.96B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $9.38B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $28.16B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
CVM VRTX REGN VRNA ARGX ALNY
Net Income $-25.41B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-17.12B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0.04B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.58
AARD Aardvark Therapeutics, Inc. Common Stock 12.71
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.05
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.565
ABPWW 0.0133
ABSI Absci Corporation 2.62
ABUS Arbutus Biopharma Corporation 4.17
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 123.055
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.29
ACIU AC Immune SA 3.03
ETFs With Exposure to CVM
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00004 341.49
IBB iShares Biotechnology ETF 0.01 172.73
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.485
VXF Vanguard Extended Market Index Fund 0.0005 218.255
IWC iShares Micro-Cap ETF 0.00106 167.885
BTEC Principal Healthcare Innovators ETF 0.03 39.49
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 247.57
VUN.TO Vanguard U.S. Total Market Index ETF 0.00004 126.01
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00004 118.61
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 115.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 115.06
VQNPX Vanguard Growth and Income Fund 0 67.73
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 110.52
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00006 52.59
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00006 52.59
VBINX Vanguard Balanced Index Fund Investor Shares 0.00006 52.59
VALT ETFMG Sit Ultra Short ETF 0.12 48.52
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.38
GERM ETFMG Treatments, Testing and Advancements ETF 0.16 19.1577
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.86
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.88
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.13
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.34
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.99
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.19 1.75
VTSAX Vanguard Total Stock Market Index Fund 0.00004 166.35
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0005 166.39
VITSX Vanguard Total Stock Market Index Fund 0.00004 166.38
DFSU Dimensional US Sustainability Core 1 ETF 0.000007 44.175
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000085398 16.7
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0005 166.41
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VTS.AX Vanguard US Total Market Shares Index ETF 0.00004 482.09
VEMPX Vanguard Extended Market Index InstlPlus 0.0005 410.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00004 312.11
Unlock